Targeted treatment and immunotherapy in older patients with advanced melanoma: A single institution real-life experience

被引：1
|
作者：
Pereira, C. [1 ]
Martins-Branco, D. [1 ]
Bexiga, C. Valente [1 ]
Monteiro, A. M. [1 ]
Nunes, H. [1 ]
Luis, A. [1 ]
Gouveia, E. [1 ]
Moreira, A. [1 ]
Passos, M. J. [1 ]
机构：
[1] Inst Portugues Oncol Lisboa Francisco Gentil EPE, Dept Med Oncol, Lisbon, Portugal
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1242
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1119P
引用
收藏
页码：S753 / S753
页数：1
相关论文
共 50 条
  • [31] Field sting reactions in patients receiving Hymenoptera venom immunotherapy: Real-life experience
    Sozener, Zeynep Celebi
    Kendirlinan, Resat
    Cerci, Pamir
    Aydin, Omur
    Mungan, Dilsad
    Bavbek, Sevim
    Demirel, Yavuz
    Misirligil, Zeynep
    Sin, Betul Ayse
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2023, 41 (03): : 186 - 192
  • [32] Cutaneous toxicities occurring in patients with melanoma receiving immunotherapy: the experience of a single large specialist institution
    Edwards, C.
    Comito, F.
    Busto, S. Agraso
    Chauhan, D.
    Turajilic, S.
    Larkin, J.
    Heelan, K.
    Fearfield, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 15 - 15
  • [33] Safety of Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) in the Real-Life Setting: A Single-Institution Experience from Argentina
    Bluthgen, M.
    Tamburelli, M.
    Calderon, C.
    Castillo, J.
    Bas, C.
    Abuin, G. Gomez
    Sena, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S536 - S536
  • [34] Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center
    Ruggeri, R. M.
    Spagnolo, C. C.
    Alibrandi, A.
    Silvestris, N.
    Cannavo, S.
    Santarpia, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (11) : 2399 - 2409
  • [35] Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center
    R. M. Ruggeri
    C. C. Spagnolo
    A. Alibrandi
    N. Silvestris
    S. Cannavò
    M. Santarpia
    Journal of Endocrinological Investigation, 2023, 46 : 2399 - 2409
  • [36] Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study
    Yu, Su-Yeon
    Mckavanagh, Dan
    McPherson, Ian
    Walpole, Euan
    Atkinson, Victoria
    Hollingworth, Samantha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (10) : 1371 - 1379
  • [37] Adjuvant treatment in elderly cancer patients: a multicenter real-life experience
    Bassanelli, M.
    Ceribelli, A.
    Giannarelli, D.
    Giacinti, S.
    Viterbo, A.
    Siringo, M.
    Poti, G.
    Roberto, M.
    Macrini, S.
    Falcone, R.
    Giuli, A.
    Di Pietro, F. R.
    Aschelter, A. M.
    Marchetti, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients
    Ellebaek, E.
    Holmstrom, R. B.
    Ruhlmann, C. H.
    Schmidt, H.
    Haslund, C. A.
    Donia, M.
    von Heymann, A.
    Johansen, C.
    Bastholt, L.
    Svane, I. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S889 - S889
  • [39] Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience
    Lavacchi, Daniele
    Roviello, Giandomenico
    Giommoni, Elisa
    Dreoni, Lorenzo
    Derio, Silvia
    Brugia, Marco
    Amedei, Amedeo
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    CANCERS, 2021, 13 (15)
  • [40] Real-Life Experience with Perampanel in 36 Patients
    Tagliafico, L.
    Di Biasio, F.
    Fancellu, R.
    Serrati, C.
    Ferrari, A.
    EPILEPSIA, 2018, 59 : S271 - S272
12345